|
DDHD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.86640000413519E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.36049999999166E-06 |
| Normal-vs-Stage2 |
4.360000E-03 |
| Normal-vs-Stage3 |
1.269960E-02 |
| Normal-vs-Stage4 |
3.260000E-01 |
| Stage1-vs-Stage2 |
1.534010E-01 |
| Stage1-vs-Stage3 |
5.020400E-01 |
| Stage1-vs-Stage4 |
3.182800E-01 |
| Stage2-vs-Stage3 |
9.273900E-02 |
| Stage2-vs-Stage4 |
1.150160E-01 |
| Stage3-vs-Stage4 |
5.617400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.73349999968531E-07 |
| Normal-vs-AfricanAmerican |
1.194680E-04 |
| Normal-vs-Asian |
2.144200E-02 |
| Caucasian-vs-AfricanAmerican |
4.012800E-01 |
| Caucasian-vs-Asian |
9.203900E-02 |
| AfricanAmerican-vs-Asian |
2.667000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87329999956631E-07 |
| Normal-vs-Female |
3.36699999992085E-07 |
| Male-vs-Female |
9.070000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.517180E-03 |
| Normal-vs-Extreme_Weight |
9.84389999999502E-05 |
| Normal-vs-Obese |
2.21489999999713E-05 |
| Normal-vs-Extreme_Obese |
7.969800E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.748600E-01 |
| Normal_Weight-vs-Obese |
2.319200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.461600E-01 |
| Extreme_Weight-vs-Obese |
1.336830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.336400E-01 |
| Obese-vs-Extreme_Obese |
2.924100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.542300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.90250001810932E-09 |
| Normal-vs-Age(61-80Yrs) |
2.45379999999074E-05 |
| Normal-vs-Age(81-100Yrs) |
8.144800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.496830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.317500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.637930E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.280000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.449820E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.305650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.839599583775E-10 |
| Normal-VS-Type2 PRCC |
2.107800E-01 |
| Normal-VS-KIRP CIMP |
1.603740E-02 |
| Normal-VS-Unclassified PRCC |
6.237700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.55537999999567E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.342400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.606800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.811700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.816200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.138360E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.463900E-03 |
| Normal-vs-N1 |
8.183800E-03 |
| Normal-vs-N2 |
9.537000E-01 |
| N0-vs-N1 |
2.026000E-01 |
| N0-vs-N2 |
3.078200E-01 |
| N1-vs-N2 |
2.361200E-01 |
|
|
